Product
Ad26.RSV.preF + RSV preF
1 clinical trial
1 indication
Indication
HealthyClinical trial
A Randomized, Double-blind, Placebo-controlled Phase 1/2a Study for Safety and Immunogenicity Evaluations for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and OlderStatus: Completed, Estimated PCD: 2022-05-16